• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Cematrix Corp
Landsea Homes Corporation - Common Stock
Sflmaven Corp
Vogenx Inc - Common Stock
YieldMax Memory and Storage Portfolio Option Income ETF
Edit Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Adicet Bio, Inc. - Common Stock (NQ:ACET)

4.570 -0.570 (-11.09%)
Delayed Quote Updated: 4:00 PM EDT, Oct 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 188,795
Open 5.140
Bid (Size) 4.580 (100)
Ask (Size) 5.370 (100)
Prev. Close 5.140
Today's Range 4.570 - 5.140
52wk Range 4.570 - 17.04
Shares Outstanding 42,957,586
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Adicet Bio’s Prula-Cel Delivers 54% Lupus Remission Rate at 12 Months ↗
October 02, 2026
Adicet Bio (NASDAQ:ACET) reported positive clinical data for prula-cel, its investigational allogeneic gamma delta CAR-T cell therapy, in patients with systemic lupus erythematosus, or SLE, including... 
Via MarketBeat
News headline image
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
September 30, 2026
From Adicet Bio, Inc.
Via Business Wire

Performance

52-Week Range 73.2% below 52-week high
4.570
4.5752W Low 17.0452W High
1 Week 21.7% below 1-week high
4.571W Low 5.841W High

Adicet Bio, Inc. - Common Stock (ACET) traded between $4.57 and $17.04 over the past 52 weeks and last traded at $4.57, 73.2% below its 52-week high. Over the past week it ranged between $4.57 and $5.84.

Past 12 Months
-17.4%
-49.5%
-43.7%
-44.4%
-48.2%
-72.5%
1W -$0.96
1M -$4.48
3M -$3.55
6M -$3.65
YTD -$4.25
1Y -$12.07

ACET was -72.5% over the past year, -44.4% over six months, -48.2% year to date, -17.4% in the last week.

12 Months vs Market
ACET
-72.5%
DIA
+13.0%
SPY
+15.5%
QQQ
+18.3%
IWM
+10.4%

Over the past 12 months ACET returned -72.5% versus DIA (Dow) +13.0%, SPY (S&P 500) +15.5%, QQQ (Nasdaq 100) +18.3% and IWM (Russell 2000) +10.4%.

Volume & Liquidity 1.03× 3-mo avg
Today 188,795 3-mo avg 183.6K
1W
234.9K
1M
330.2K
3M
183.6K
6M
141.8K
YTD
150.1K
1Y
150.4K

ACET most recently traded 188,795 shares against a 3-month average daily volume of 183.6K.

More News

Read More
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
September 28, 2026
Via Chartmill
News headline image
Adicet Bio Announces Positive Safety and Efficacy Data from Prula-cel (formerly ADI-001) Study in Patients with Systemic Lupus Erythematosus with or without Lupus Nephritis
September 28, 2026
From Adicet Bio, Inc.
Via Business Wire
Curious about the stocks that are showing activity after the closing bell on Friday? ↗
September 25, 2026
Via Chartmill
News headline image
Adicet Bio to Host Webcast to Present Prula-cel (formerly ADI-001) Clinical Data in Patients with Systemic Lupus Erythematosus with or without Lupus Nephritis
September 25, 2026
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio to Participate in Fireside Chat at H.C. Wainwright 28th Annual Global Investment Conference
September 02, 2026
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio Announces Completion of Last Patient Visit for Planned Analysis of prula-cel (formerly ADI-001) Study in Patients with Systemic Lupus Erythematosus With or Without Lupus Nephritis and Provides Corporate Update
September 01, 2026
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
August 31, 2026
From Adicet Bio, Inc.
Via Business Wire
News headline image
Johnson & Johnson Owns Stakes in 15 Stocks. Here's the Best of the Bunch. ↗
August 31, 2026
Via The Motley Fool
News headline image
Adicet Bio Announces FDA Clearance of IND Application for ADI-212
August 27, 2026
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio Eyes Key Lupus Data This Quarter for Off-the-Shelf Cell Therapy ↗
August 11, 2026
Via MarketBeat
News headline image
Adicet Bio Reports Second Quarter 2026 Financial Results and Provides Business Updates
August 05, 2026
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio to Participate in Fireside Chat at Canaccord Genuity 46th Annual Growth Conference
July 21, 2026
From Adicet Bio, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
June 25, 2026
Via Benzinga
News headline image
Adicet Bio Teases Autoimmune Data Catalysts, PSMA Plans at Jefferies Conference ↗
June 04, 2026
Via MarketBeat
News headline image
Adicet Bio to Participate in Fireside Chat at Jefferies Global Healthcare Conference
May 14, 2026
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio Reports First Quarter 2026 Financial Results and Provides Business Updates
May 13, 2026
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Company Progress
March 12, 2026
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026
January 30, 2026
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio Provides Corporate Update and Highlights Expected 2026 Milestones
January 07, 2026
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio Announces Reverse Stock Split
December 26, 2025
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
November 28, 2025
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio Reports Third Quarter 2025 Financial Results and Provides Business Updates
November 05, 2025
From Adicet Bio, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
November 04, 2025
Via Benzinga

Frequently Asked Questions

Is Adicet Bio, Inc. - Common Stock publicly traded?
Yes, Adicet Bio, Inc. - Common Stock is publicly traded.
What exchange does Adicet Bio, Inc. - Common Stock trade on?
Adicet Bio, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Adicet Bio, Inc. - Common Stock?
The ticker symbol for Adicet Bio, Inc. - Common Stock is ACET on the Nasdaq Stock Market
What is the current price of Adicet Bio, Inc. - Common Stock?
The current price of Adicet Bio, Inc. - Common Stock is 4.570
When was Adicet Bio, Inc. - Common Stock last traded?
The last trade of Adicet Bio, Inc. - Common Stock was at 10/16/26 04:00 PM ET
What is the market capitalization of Adicet Bio, Inc. - Common Stock?
The market capitalization of Adicet Bio, Inc. - Common Stock is 196.32M
How many shares of Adicet Bio, Inc. - Common Stock are outstanding?
Adicet Bio, Inc. - Common Stock has 196M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap